Order Article Reprints

Podlipnik S, Boada A, López-Estebaranz JL, Martín-González MM, Redondo P, Martin B, Quick AP, Bailey CN, Kurley SJ, Cook RW, et al. Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study. Cancers. 2022; 14(4):1060. https://doi.org/10.3390/cancers14041060

Podlipnik, Sebastian, Aram Boada, Jose L. López-Estebaranz, Manuel M. Martín-González, Pedro Redondo, Brian Martin, Ann P. Quick, Christine N. Bailey, Sarah J. Kurley, Robert W. Cook, and et al. 2022. "Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study" Cancers 14, no. 4: 1060. https://doi.org/10.3390/cancers14041060

Podlipnik, S., Boada, A., López-Estebaranz, J. L., Martín-González, M. M., Redondo, P., Martin, B., Quick, A. P., Bailey, C. N., Kurley, S. J., Cook, R. W., & Puig, S. (2022). Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I–II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study. Cancers, 14(4), 1060. https://doi.org/10.3390/cancers14041060